Phosphoglycan beta 1,3 galactosyltransferase (required for proper protective coat formation). Probably part of a much larger group. Expanded in Leishmaniids. Localization: Golgi (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 60 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 52 |
NetGPI | no | yes: 0, no: 52 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 53 |
GO:0110165 | cellular anatomical entity | 1 | 53 |
GO:0000139 | Golgi membrane | 5 | 13 |
GO:0031090 | organelle membrane | 3 | 13 |
GO:0098588 | bounding membrane of organelle | 4 | 13 |
Related structures:
AlphaFold database: A4H3B6
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 53 |
GO:0006807 | nitrogen compound metabolic process | 2 | 53 |
GO:0008152 | metabolic process | 1 | 53 |
GO:0019538 | protein metabolic process | 3 | 53 |
GO:0036211 | protein modification process | 4 | 53 |
GO:0043170 | macromolecule metabolic process | 3 | 53 |
GO:0043412 | macromolecule modification | 4 | 53 |
GO:0043413 | macromolecule glycosylation | 3 | 53 |
GO:0044238 | primary metabolic process | 2 | 53 |
GO:0070085 | glycosylation | 2 | 53 |
GO:0071704 | organic substance metabolic process | 2 | 53 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 53 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 53 |
GO:0016740 | transferase activity | 2 | 53 |
GO:0016757 | glycosyltransferase activity | 3 | 53 |
GO:0016758 | hexosyltransferase activity | 4 | 53 |
GO:0008194 | UDP-glycosyltransferase activity | 4 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.540 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.513 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.583 |
CLV_NRD_NRD_1 | 315 | 317 | PF00675 | 0.710 |
CLV_NRD_NRD_1 | 320 | 322 | PF00675 | 0.705 |
CLV_NRD_NRD_1 | 399 | 401 | PF00675 | 0.692 |
CLV_NRD_NRD_1 | 572 | 574 | PF00675 | 0.538 |
CLV_NRD_NRD_1 | 641 | 643 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 659 | 661 | PF00675 | 0.519 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.608 |
CLV_PCSK_KEX2_1 | 315 | 317 | PF00082 | 0.708 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.702 |
CLV_PCSK_KEX2_1 | 399 | 401 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 572 | 574 | PF00082 | 0.592 |
CLV_PCSK_KEX2_1 | 640 | 642 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 659 | 661 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 682 | 684 | PF00082 | 0.578 |
CLV_PCSK_PC1ET2_1 | 640 | 642 | PF00082 | 0.577 |
CLV_PCSK_PC1ET2_1 | 682 | 684 | PF00082 | 0.560 |
CLV_PCSK_PC7_1 | 316 | 322 | PF00082 | 0.584 |
CLV_PCSK_PC7_1 | 568 | 574 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.611 |
CLV_PCSK_SKI1_1 | 316 | 320 | PF00082 | 0.635 |
CLV_PCSK_SKI1_1 | 388 | 392 | PF00082 | 0.466 |
CLV_PCSK_SKI1_1 | 424 | 428 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 521 | 525 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 568 | 572 | PF00082 | 0.495 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 679 | 683 | PF00082 | 0.520 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.553 |
DEG_SCF_FBW7_1 | 360 | 367 | PF00400 | 0.504 |
DOC_CKS1_1 | 361 | 366 | PF01111 | 0.511 |
DOC_CYCLIN_yCln2_LP_2 | 358 | 364 | PF00134 | 0.535 |
DOC_CYCLIN_yCln2_LP_2 | 47 | 53 | PF00134 | 0.362 |
DOC_MAPK_JIP1_4 | 4 | 10 | PF00069 | 0.581 |
DOC_MAPK_MEF2A_6 | 144 | 152 | PF00069 | 0.352 |
DOC_MAPK_MEF2A_6 | 2 | 10 | PF00069 | 0.700 |
DOC_MAPK_MEF2A_6 | 388 | 395 | PF00069 | 0.444 |
DOC_MAPK_MEF2A_6 | 412 | 421 | PF00069 | 0.340 |
DOC_PP1_RVXF_1 | 386 | 393 | PF00149 | 0.337 |
DOC_PP1_RVXF_1 | 422 | 429 | PF00149 | 0.431 |
DOC_PP1_RVXF_1 | 580 | 586 | PF00149 | 0.264 |
DOC_PP2B_LxvP_1 | 358 | 361 | PF13499 | 0.530 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.369 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.434 |
DOC_USP7_MATH_1 | 365 | 369 | PF00917 | 0.327 |
DOC_USP7_MATH_1 | 479 | 483 | PF00917 | 0.388 |
DOC_USP7_MATH_1 | 661 | 665 | PF00917 | 0.305 |
DOC_USP7_MATH_1 | 75 | 79 | PF00917 | 0.314 |
DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.405 |
DOC_WW_Pin1_4 | 327 | 332 | PF00397 | 0.534 |
DOC_WW_Pin1_4 | 360 | 365 | PF00397 | 0.474 |
DOC_WW_Pin1_4 | 612 | 617 | PF00397 | 0.310 |
DOC_WW_Pin1_4 | 681 | 686 | PF00397 | 0.347 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.345 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.376 |
LIG_14-3-3_CanoR_1 | 218 | 222 | PF00244 | 0.470 |
LIG_14-3-3_CanoR_1 | 262 | 267 | PF00244 | 0.435 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.346 |
LIG_14-3-3_CanoR_1 | 321 | 331 | PF00244 | 0.403 |
LIG_14-3-3_CanoR_1 | 481 | 485 | PF00244 | 0.406 |
LIG_14-3-3_CanoR_1 | 549 | 555 | PF00244 | 0.314 |
LIG_14-3-3_CanoR_1 | 76 | 84 | PF00244 | 0.336 |
LIG_Actin_WH2_2 | 158 | 174 | PF00022 | 0.381 |
LIG_Actin_WH2_2 | 558 | 574 | PF00022 | 0.288 |
LIG_BIR_III_2 | 670 | 674 | PF00653 | 0.288 |
LIG_BRCT_BRCA1_1 | 274 | 278 | PF00533 | 0.399 |
LIG_CtBP_PxDLS_1 | 252 | 256 | PF00389 | 0.411 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.518 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.511 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.357 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.415 |
LIG_FHA_1 | 346 | 352 | PF00498 | 0.458 |
LIG_FHA_1 | 510 | 516 | PF00498 | 0.284 |
LIG_FHA_2 | 301 | 307 | PF00498 | 0.401 |
LIG_FHA_2 | 708 | 714 | PF00498 | 0.309 |
LIG_Integrin_RGD_1 | 598 | 600 | PF01839 | 0.535 |
LIG_LIR_Apic_2 | 410 | 416 | PF02991 | 0.471 |
LIG_LIR_Apic_2 | 714 | 720 | PF02991 | 0.259 |
LIG_LIR_Gen_1 | 17 | 26 | PF02991 | 0.224 |
LIG_LIR_Gen_1 | 363 | 373 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 447 | 457 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 48 | 55 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 548 | 556 | PF02991 | 0.377 |
LIG_LIR_Gen_1 | 600 | 609 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 629 | 635 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 17 | 21 | PF02991 | 0.234 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 220 | 224 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 363 | 369 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 447 | 453 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 548 | 554 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 600 | 604 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 605 | 609 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 629 | 634 | PF02991 | 0.302 |
LIG_NRBOX | 39 | 45 | PF00104 | 0.333 |
LIG_NRBOX | 514 | 520 | PF00104 | 0.235 |
LIG_NRBOX | 561 | 567 | PF00104 | 0.274 |
LIG_Pex14_1 | 503 | 507 | PF04695 | 0.256 |
LIG_Pex14_1 | 705 | 709 | PF04695 | 0.272 |
LIG_PTB_Apo_2 | 501 | 508 | PF02174 | 0.256 |
LIG_REV1ctd_RIR_1 | 623 | 632 | PF16727 | 0.285 |
LIG_SH2_CRK | 450 | 454 | PF00017 | 0.246 |
LIG_SH2_CRK | 551 | 555 | PF00017 | 0.303 |
LIG_SH2_CRK | 631 | 635 | PF00017 | 0.289 |
LIG_SH2_CRK | 717 | 721 | PF00017 | 0.306 |
LIG_SH2_NCK_1 | 291 | 295 | PF00017 | 0.440 |
LIG_SH2_NCK_1 | 687 | 691 | PF00017 | 0.353 |
LIG_SH2_NCK_1 | 717 | 721 | PF00017 | 0.270 |
LIG_SH2_SRC | 224 | 227 | PF00017 | 0.341 |
LIG_SH2_SRC | 431 | 434 | PF00017 | 0.361 |
LIG_SH2_SRC | 621 | 624 | PF00017 | 0.274 |
LIG_SH2_STAP1 | 119 | 123 | PF00017 | 0.434 |
LIG_SH2_STAP1 | 431 | 435 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 631 | 635 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 196 | 199 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 353 | 356 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 372 | 375 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 462 | 465 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 621 | 624 | PF00017 | 0.448 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.445 |
LIG_SH3_3 | 246 | 252 | PF00018 | 0.332 |
LIG_SH3_3 | 326 | 332 | PF00018 | 0.364 |
LIG_SH3_3 | 358 | 364 | PF00018 | 0.508 |
LIG_SH3_3 | 468 | 474 | PF00018 | 0.363 |
LIG_SH3_3 | 520 | 526 | PF00018 | 0.322 |
LIG_SUMO_SIM_anti_2 | 17 | 23 | PF11976 | 0.272 |
LIG_SUMO_SIM_anti_2 | 65 | 72 | PF11976 | 0.329 |
LIG_SUMO_SIM_par_1 | 251 | 259 | PF11976 | 0.407 |
LIG_SUMO_SIM_par_1 | 65 | 72 | PF11976 | 0.321 |
LIG_SUMO_SIM_par_1 | 89 | 94 | PF11976 | 0.339 |
LIG_TRAF2_1 | 223 | 226 | PF00917 | 0.350 |
LIG_TYR_ITIM | 222 | 227 | PF00017 | 0.544 |
LIG_UBA3_1 | 43 | 49 | PF00899 | 0.420 |
LIG_WW_3 | 190 | 194 | PF00397 | 0.407 |
MOD_CK1_1 | 340 | 346 | PF00069 | 0.587 |
MOD_CK1_1 | 349 | 355 | PF00069 | 0.471 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.406 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.474 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.664 |
MOD_CK2_1 | 365 | 371 | PF00069 | 0.462 |
MOD_Cter_Amidation | 638 | 641 | PF01082 | 0.371 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.582 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.592 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.378 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.418 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.586 |
MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.452 |
MOD_GlcNHglycan | 339 | 342 | PF01048 | 0.521 |
MOD_GlcNHglycan | 348 | 351 | PF01048 | 0.598 |
MOD_GlcNHglycan | 354 | 357 | PF01048 | 0.551 |
MOD_GlcNHglycan | 377 | 380 | PF01048 | 0.577 |
MOD_GlcNHglycan | 636 | 639 | PF01048 | 0.452 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.531 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.680 |
MOD_GSK3_1 | 297 | 304 | PF00069 | 0.445 |
MOD_GSK3_1 | 336 | 343 | PF00069 | 0.647 |
MOD_GSK3_1 | 345 | 352 | PF00069 | 0.530 |
MOD_GSK3_1 | 356 | 363 | PF00069 | 0.511 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.509 |
MOD_GSK3_1 | 630 | 637 | PF00069 | 0.394 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.402 |
MOD_N-GLC_1 | 272 | 277 | PF02516 | 0.539 |
MOD_N-GLC_1 | 301 | 306 | PF02516 | 0.440 |
MOD_N-GLC_1 | 479 | 484 | PF02516 | 0.511 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.535 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.366 |
MOD_NEK2_1 | 278 | 283 | PF00069 | 0.471 |
MOD_NEK2_1 | 337 | 342 | PF00069 | 0.463 |
MOD_NEK2_1 | 407 | 412 | PF00069 | 0.509 |
MOD_NEK2_1 | 634 | 639 | PF00069 | 0.406 |
MOD_NEK2_2 | 495 | 500 | PF00069 | 0.303 |
MOD_NEK2_2 | 99 | 104 | PF00069 | 0.655 |
MOD_PIKK_1 | 419 | 425 | PF00454 | 0.548 |
MOD_PK_1 | 49 | 55 | PF00069 | 0.385 |
MOD_PKA_1 | 399 | 405 | PF00069 | 0.643 |
MOD_PKA_2 | 217 | 223 | PF00069 | 0.580 |
MOD_PKA_2 | 337 | 343 | PF00069 | 0.643 |
MOD_PKA_2 | 399 | 405 | PF00069 | 0.591 |
MOD_PKA_2 | 480 | 486 | PF00069 | 0.426 |
MOD_PKA_2 | 62 | 68 | PF00069 | 0.467 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.380 |
MOD_Plk_1 | 479 | 485 | PF00069 | 0.453 |
MOD_Plk_1 | 602 | 608 | PF00069 | 0.403 |
MOD_Plk_2-3 | 254 | 260 | PF00069 | 0.568 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.326 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.498 |
MOD_Plk_4 | 349 | 355 | PF00069 | 0.458 |
MOD_Plk_4 | 509 | 515 | PF00069 | 0.320 |
MOD_Plk_4 | 550 | 556 | PF00069 | 0.356 |
MOD_Plk_4 | 605 | 611 | PF00069 | 0.504 |
MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.485 |
MOD_ProDKin_1 | 327 | 333 | PF00069 | 0.663 |
MOD_ProDKin_1 | 360 | 366 | PF00069 | 0.585 |
MOD_ProDKin_1 | 612 | 618 | PF00069 | 0.351 |
MOD_ProDKin_1 | 681 | 687 | PF00069 | 0.401 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.407 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.440 |
TRG_DiLeu_BaLyEn_6 | 39 | 44 | PF01217 | 0.388 |
TRG_DiLeu_BaLyEn_6 | 514 | 519 | PF01217 | 0.403 |
TRG_DiLeu_BaLyEn_6 | 87 | 92 | PF01217 | 0.407 |
TRG_ENDOCYTIC_2 | 196 | 199 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 224 | 227 | PF00928 | 0.587 |
TRG_ENDOCYTIC_2 | 433 | 436 | PF00928 | 0.569 |
TRG_ENDOCYTIC_2 | 450 | 453 | PF00928 | 0.264 |
TRG_ENDOCYTIC_2 | 551 | 554 | PF00928 | 0.493 |
TRG_ENDOCYTIC_2 | 601 | 604 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 631 | 634 | PF00928 | 0.332 |
TRG_ER_diArg_1 | 30 | 32 | PF00400 | 0.454 |
TRG_ER_diArg_1 | 314 | 316 | PF00400 | 0.646 |
TRG_ER_diArg_1 | 319 | 321 | PF00400 | 0.611 |
TRG_ER_diArg_1 | 399 | 401 | PF00400 | 0.484 |
TRG_ER_diArg_1 | 571 | 573 | PF00400 | 0.419 |
TRG_NLS_MonoExtC_3 | 403 | 409 | PF00514 | 0.441 |
TRG_NLS_MonoExtN_4 | 401 | 408 | PF00514 | 0.496 |
TRG_Pf-PMV_PEXEL_1 | 405 | 409 | PF00026 | 0.458 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IGN9 | Leishmania donovani | 41% | 89% |
A0A3S5H4Y6 | Leishmania donovani | 63% | 89% |
A0A3S5H4Y9 | Leishmania donovani | 38% | 73% |
A0A3S7WT86 | Leishmania donovani | 39% | 70% |
A0A3S7WWA6 | Leishmania donovani | 41% | 89% |
A0A451EJD9 | Leishmania donovani | 39% | 89% |
A0A451EJF4 | Leishmania donovani | 64% | 88% |
A0A451EJF6 | Leishmania donovani | 55% | 100% |
A0A451EJF8 | Leishmania donovani | 58% | 94% |
A0A451EJF9 | Leishmania donovani | 50% | 84% |
A4H3A9 | Leishmania braziliensis | 86% | 99% |
A4H3B4 | Leishmania braziliensis | 79% | 100% |
A4H3B5 | Leishmania braziliensis | 92% | 100% |
A4H3B8 | Leishmania braziliensis | 61% | 87% |
A4H3B9 | Leishmania braziliensis | 40% | 81% |
A4H4W8 | Leishmania braziliensis | 39% | 89% |
A4HJ20 | Leishmania braziliensis | 94% | 89% |
A4HNK3 | Leishmania braziliensis | 41% | 100% |
A4HNK6 | Leishmania braziliensis | 38% | 91% |
A4HRL9 | Leishmania infantum | 64% | 88% |
A4HRM0 | Leishmania infantum | 65% | 98% |
A4HRM1 | Leishmania infantum | 55% | 100% |
A4HRS1 | Leishmania infantum | 50% | 84% |
A4HRS3 | Leishmania infantum | 39% | 73% |
A4HRS5 | Leishmania infantum | 58% | 94% |
A4HZM0 | Leishmania infantum | 39% | 88% |
A4I7C7 | Leishmania infantum | 40% | 88% |
A4IAQ2 | Leishmania infantum | 38% | 89% |
E9AC91 | Leishmania major | 60% | 100% |
E9AC92 | Leishmania major | 59% | 100% |
E9AC95 | Leishmania major | 56% | 100% |
E9AC96 | Leishmania major | 50% | 100% |
E9AC98 | Leishmania major | 38% | 73% |
E9AEH8 | Leishmania major | 38% | 100% |
E9AHA6 | Leishmania infantum | 39% | 89% |
E9AIP8 | Leishmania braziliensis | 38% | 100% |
E9AJI3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 65% | 88% |
E9AJI4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 62% | 90% |
E9AJI5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 60% | 93% |
E9AJI6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 73% |
E9ALD6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 97% |
E9ASB8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 89% |
E9AXX8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 88% |
E9B2C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 89% |
Q4Q5T6 | Leishmania major | 39% | 100% |
Q4QCL8 | Leishmania major | 38% | 100% |
Q4QFJ3 | Leishmania major | 39% | 70% |
Q4QIG9 | Leishmania major | 39% | 100% |
Q7YXU9 | Leishmania major | 40% | 100% |
Q7YXV1 | Leishmania major | 39% | 100% |
Q7YXV2 | Leishmania major | 38% | 100% |